Discrete molecular classes of ovarian cancer suggestive of unique mechanisms of transformation and metastases

Clinical Cancer Research

Volumn 20, Issue 1, 2014, Pages 87-99

  Gardi, Nilesh L ^a   Deshpande, Tejaswini U ^a   Kamble, Swapnil C ^a   Budhe, Sagar R ^a   Bapat, Sharmila A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OSTEONECTIN; PROTEIN FN1; PROTEIN P53; PROTEIN PEG3; PROTEIN TCF21; REGULATOR PROTEIN; THROMBOSPONDIN 2; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER SURVIVAL; CELL DIFFERENTIATION; DNA DAMAGE; EPITHELIAL MESENCHYMAL TRANSITION; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC TRANSFORMATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HUMAN; IMMUNE EVASION; IMMUNOHISTOCHEMISTRY; METASTASIS; MOLECULAR INTERACTION; ONCOGENE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VALIDATION STUDY;

CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYSTADENOCARCINOMA, SEROUS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENETIC LINKAGE; GENOMIC INSTABILITY; HUMANS; OVARIAN NEOPLASMS; OXIDATIVE STRESS; TRANSCRIPTOME;

EID: 84892142697     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2063     Document Type: Article

References (50)

1. Kurrey NK, K Amit, Bapat SA. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005;97:155-65.
2. Huber MA, Kraut N, Beug H. Molecular requirements for epithelialmesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17:548-58.
3. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008;27:6958-69.
4. Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 2007; 213:581-8.
5. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94.
6. Samadi N, Bekele R, Capatos D, Venkatraman G, Sariahmetoglu M, Brindley DN. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie 2011; 93:61-70.
7. Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia? Lancet 1971;2:163.
8. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22:255-88.
9. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007;211:26-35.
10. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol 2008;9:1191-7.
11. Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012;55:3-23.
12. Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 2008;109:68-173.
13. Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol 2009;22:1133-8.
14. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
15. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005;65:3025-9.
16. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, et al. Snail and Slug mediate radio- and chemo-resistance by antagonizing p53-mediated apoptosis and acquiring a stemlike phenotype in ovarian cancer cells. Stem Cells 2009;27:2059-68.
17. Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 1987;20:53-65.
18. Monti S, Tamayo P, Mesirov J, Golub T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 2003;52:91-118.
19. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, Castellanos R, et al. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet 2006;2:e130.
20. Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible? PloS Comp Biol 2011;7:e1001057.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50.
22. Geback T, Schulz MM, Koumoutsakos P, Detmar M. TS cratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009;46:265-74.
23. HärmäV, Virtanen J, MäkeläR, Happonen A, Mpindi JP, Knuuttila M, et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010;5:e10431.
24. Lizard G, Gueldry S, Sordet O, Monier S, Athias A, Miquet C, et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998;12:1651-63.
25. Wani AA, Sharma N, Shouche YS, Bapat SA. Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. Oncogene 2006;25:6336-44.
26. Bapat SA, Krishnan A, Ghanate AD, Kusumbe AP, Kalra RS. Gene expression: protein interaction systems network modeling identifies transformation- associated molecules and pathways in ovarian cancer. Cancer Res 2010;70:4809-19.
27. Gene omnibus database http://www.ncbi.nlm.nih.gov/geo; 2012.
28. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559.
29. Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006;7 Suppl 1:S7.
30. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin's dark side: possible role in tumor progression. Biochim Biophys Acta 2012;1826:23-31.
31. Yaginuma Y, Westphal H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res 1992; 52:4196-9.
32. Donoho G, Brenneman MA, Cui TX, Donoviel D, Vogel H, Goodwin EH, et al. Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice. Genes Chromosomes Cancer 2003;36:317-31.
33. Richards KL, Zhang B, Sun M, Dong W, Churchill J, Bachinski LL, et al. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage non-small cell lung cancers. Cancer 2011;117:606-17.
34. Hiby SE, Lough M, Keverne EB, Surani MA, Loke YW, King A. Paternal monoallelic expression of PEG3 in the human placenta. Hum Mol Genet 2001;10:1093-100.
35. Kurman RJ, Shih I. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-43.
36. Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, et al. Integrated analyses identify a master Micro RNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cell 2013;23:186-99.
37. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome gene expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010; 107:15449-54.
38. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 2009;106:13820-5.
39. Berns EM, Bowtel DD. The changing view of high-grade serous ovarian cancer. Cancer Res 2012;72:2701-4.
40. Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM. Highgrade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci U S A 2012;109:3921-6.
41. Crum CP. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 2009;3:165-70.
42. Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA. Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest 1994;71:510-8.
43. Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res 1994;215:97-108.
44. Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, et al. The Epithelial-Mesenchymal Transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PloS One 2012;7:e40378.
45. Bi XL, Yang W. Biological functions of decorin in cancer. Chin J Cancer 2013;32:266-9.
46. Peng J, Zhang G, Wang Q, Huang J, Ma H, Zhong Y, et al. ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells. Biosci Biotechnol Biochem 2012;76:42-7.
47. Zhou B, von Gise A, Ma Q, Hu YW, Pu WT. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol 2010;338:251-61.
48. Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, et al. Resveratrol inhibits TGF-b1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 2013;303:139-46.
49. Nash MA, Ferrandina G, Gordinier M, Loercher A, Freedman RS. The role of cytokines in both the normal and malignant ovary. Endocr Relat Cancer 1999;6:93-107.
50. Ziltener HJ, Maines-Bandiera S, Schrader JW, Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol Reprod 1993;49:635-41.